Antimalarial pharmacology and therapeutics of atovaquone
Open Access
- 4 January 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 68 (5) , 977-985
Abstract
Atovaquone is used as a fixed-dose combination with proguanil (Malarone) for treating children and adults with uncomplicated malaria or as chemoprophylaxis for preventing malaria in travellers. Indeed, in the USA, between 2009 and 2011, Malarone prescriptions accounted for 70% of all antimalarial pre-travel prescriptions. In 2013 the patent for Malarone will expire, potentially resulting in a wave of low-cost generics. Furthermore, the malaria scientific community has a number of antimalarial quinolones with a related pharmacophore to atovaquone at various stages of pre-clinical development. With this in mind, it is timely here to review the current knowledge of atovaquone, with the purpose of aiding the decision making of clinicians and drug developers involved in the future use of atovaquone generics or atovaquone derivatives.Keywords
This publication has 76 references indexed in Scilit:
- Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malariaProceedings of the National Academy of Sciences, 2012
- Lead Optimization of 3-Carboxyl-4(1H)-Quinolones to Deliver Orally Bioavailable AntimalarialsJournal of Medicinal Chemistry, 2012
- Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein ExpressionJournal of Biological Chemistry, 2012
- Metabolic Fate of Fumarate, a Side Product of the Purine Salvage Pathway in the Intraerythrocytic Stages of Plasmodium falciparumJournal of Biological Chemistry, 2011
- Optimization of endochin-like quinolones for antimalarial activityExperimental Parasitology, 2011
- Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with ZidovudineDrug Metabolism and Disposition, 2009
- Preventing malaria in travellersBMJ, 2008
- A drug-selected Plasmodium falciparum lacking the need for conventional electron transportMolecular and Biochemical Parasitology, 2008
- Antimalarial quinolones: Synthesis, potency, and mechanistic studiesExperimental Parasitology, 2008
- Functional Characterization and Target Validation of Alternative Complex I of Plasmodium falciparum MitochondriaAntimicrobial Agents and Chemotherapy, 2006